11561987

Source:http://linkedlifedata.com/resource/pubmed/id/11561987

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007138, umls-concept:C0600688, umls-concept:C0814812, umls-concept:C1883256
pubmed:issue	3
pubmed:dateCreated	2001-9-19
pubmed:abstractText	Chemotherapy for urothelial transitional cell carcinoma improves disease-related symptoms and overall survival. Unfortunately, many commonly used cytotoxic regimens affect normal as well as malignant tissue, resulting in toxicities that may require prompt medical diagnosis and management. This article reviews the reported toxicities of both single agent and combination chemotherapy regimens used to treat metastatic transitional cell carcinoma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9514993
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1081-0943
pubmed:author	pubmed-author:MoulderS LSL, pubmed-author:RothB JBJ
pubmed:issnType	Print
pubmed:volume	19
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	194-201
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11561987-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11561987-Bone Marrow Diseases, pubmed-meshheading:11561987-Carcinoma, Transitional Cell, pubmed-meshheading:11561987-Deafness, pubmed-meshheading:11561987-Humans, pubmed-meshheading:11561987-Nervous System Diseases, pubmed-meshheading:11561987-Urinary Bladder Neoplasms
pubmed:year	2001
pubmed:articleTitle	Systemic chemotherapy for urothelial transitional cell carcinoma: an overview of toxicity.
pubmed:affiliation	Genitourinary Oncology Program, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232-6307, USA.
pubmed:publicationType	Journal Article, Review